Impact of Crystal Polymorphism on the Systemic Bioavailability of Rifaximin, an Antibiotic Acting Locally in the Gastrointestinal Tract, in Healthy Volunteers

Drug Design, Development and Therapy - New Zealand

doi 10.2147/dddt.s72572